Fludeoxyglucose

Product NDC
76451-118
Requested package NDC
76451-118-51
11-digit product format
764510118
Labeler code
76451
Product ID
76451-118_47434382-85a5-899c-e063-6294a90ad8d9
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Fludeoxyglucose F18
Dosage form
INJECTION
Route
INTRAVENOUS
Labeler
3D Imaging Drug Design and Development LLC
Application
ANDA203778
Marketing category
ANDA
Marketing start
2012-01-02
Substance
FLUDEOXYGLUCOSE F-18
Active strength
300 mCi/mL
Pharmacologic classes
Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 16 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-288af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-081332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29fb8cb913e6d1…eb8c232b6be0…

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A203778-001FLUDEOXYGLUCOSE F18FLUDEOXYGLUCOSE F-1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A203778-001AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-3031067a03dcf5…
2025-08-23 18:47 UTC2025-08A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-306a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-3003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-302680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-305bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-3079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-301e350fbaab3a…
2024-05-31 18:47 UTC2024-05A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-308072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-305c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-305d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-304b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-3074a2ff9319b5…
2022-03-09 01:35 UTC2022-03A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-3087673890dc5c…
2021-03-12 10:30 UTC2021-03A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-305aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-308869cabd3fbd…
2020-11-12 02:37 UTC2020-11A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30c0c555d07b60…
2019-12-14 00:12 UTC2019-12A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-303f01610625f2…
2019-09-15 20:21 UTC2019-09A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30b00525d2431f…
2019-07-19 19:46 UTC2019-07A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-306a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-301c564ffb4f44…
2023-12-20 04:57 UTC2023-12A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-309b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-303f0d92c62455…
2023-05-13 08:27 UTC2023-05A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30053a50430f4f…
2023-01-26 05:58 UTC2023-01A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-303bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-303a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A203778-001FLUDEOXYGLUCOSE F1820-300mCi/MLINJECTABLE / INTRAVENOUSAP2015-10-30e64feba35796…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A203778-001AP1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A203778-001AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A203778-001AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08A203778-001AP16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A203778-001AP1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A203778-001AP1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A203778-001AP103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A203778-001AP12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A203778-001AP15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A203778-001AP1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A203778-001AP1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A203778-001AP179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A203778-001AP1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A203778-001AP11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A203778-001AP18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A203778-001AP15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A203778-001AP15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A203778-001AP14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A203778-001AP174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A203778-001AP1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A203778-001AP1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A203778-001AP187673890dc5c…
2021-03-12 10:30 UTC2021-03A203778-001AP15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A203778-001AP18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A203778-001AP1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A203778-001AP13f01610625f2…
2019-09-15 20:21 UTC2019-09A203778-001AP1b00525d2431f…
2019-07-19 19:46 UTC2019-07A203778-001AP1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A203778-001AP16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A203778-001AP11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A203778-001AP1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A203778-001AP1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A203778-001AP19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A203778-001AP1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A203778-001AP13f0d92c62455…
2023-05-13 08:27 UTC2023-05A203778-001AP1053a50430f4f…
2023-01-26 05:58 UTC2023-01A203778-001AP13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A203778-001AP13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A203778-001AP1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A203778-001AP1e64feba35796…

Additional Listing Data#

Finished product
Yes
Brand name base
Fludeoxyglucose
Brand name suffix
F18
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
FLUDEOXYGLUCOSE F-18300 mCi/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
0Z5B2CJX4DInternal UNII lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2785ce60-86c9-42c2-ab0a-8c5d5adf60d3Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a8297d3a-f6a8-4d2b-8fce-c063a35f1186Product name220251210
858c9b08-fb6b-48b9-8516-ea929654e228Product name220160606
6d7dfd10-cccc-49a1-a5c7-1842491e3644Product name220151125
b370ef4e-503e-4658-af90-e40f1dd3ff26Product name920151106
a838cd4c-e408-4023-a03d-912949043ddcProduct name220151029
bce34a5c-800a-42cd-a264-d5a0d09eed8aProduct name120150902
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
99a01b5c-59f4-409d-9148-0a2993e6f287Product name120150507

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
76451-118-102026-01-06These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X
76451-118-112026-01-06These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X
76451-118-302026-01-06These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X
76451-118-512026-01-06These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X
76451-118-102023-01-30These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X
76451-118-112023-01-30These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X
76451-118-302023-01-30These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X
76451-118-512023-01-30These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X
76451-118-102022-11-10These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X
76451-118-112022-11-10These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X
76451-118-302022-11-10These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X
76451-118-512022-11-10These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X
76451-118-102022-07-29These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X
76451-118-112022-07-29These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X
76451-118-302022-07-29These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X
76451-118-512022-07-29These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection for intravenous use Initial U.S. Approval: 200X

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76451-118-10FludeoxyglucoseF1810 mL in 1 VIAL, GLASSINJECTION103
76451-118-30FludeoxyglucoseF1830 mL in 1 VIAL, GLASSINJECTION303

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
76451-118FLUDEOXYGLUCOSE F18 INJECTION [3D IMAGING DRUG DESIGN AND DEVELOPMENT LLC]1Current NDC, Legacy NDC, 2 package rows20190215_2785ce60-86c9-42c2-ab0a-8c5d5adf60d3.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Fludeoxyglucose F18FLUDEOXYGLUCOSE F183D Imaging Drug Design and Development LLC2785ce60-86c9-42c2-ab0a-8c5d5adf60d32025-12-31Warnings, Adverse reactionsExact identifier
application applno (ANDA): 203778
application number: ANDA203778
ndc (product): 76451-118

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
76451-118-517645101185110 mL in 1 SYRINGE, PLASTIC (76451-118-51) 10 ml2018-12-170000-00-00NoNoCurrent